Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1129 entries
Sorted by: Best Match Show Resources per page
CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells.

BioResearch open access

Peters EB, Christoforou N, Moore E, West JL, Truskey GA.
PMID: 26309784
Biores Open Access. 2015 Jan 01;4(1):75-88. doi: 10.1089/biores.2014.0029. eCollection 2015.

Mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs) represent promising cell sources for angiogenic therapies. There are, however, conflicting reports regarding the ability of MSCs to support network formation of endothelial cells. The goal of this study was...

Cite
Peters EB, Christoforou N, Moore E, et al. CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells. Biores Open Access. 2015;4(1):75-88doi: 10.1089/biores.2014.0029.
Peters, E. B., Christoforou, N., Moore, E., West, J. L., & Truskey, G. A. (2015). CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells. BioResearch open access, 4(1), 75-88. https://doi.org/10.1089/biores.2014.0029
Peters, Erica B, et al. "CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells." BioResearch open access vol. 4,1 (2015): 75-88. doi: https://doi.org/10.1089/biores.2014.0029
Peters EB, Christoforou N, Moore E, West JL, Truskey GA. CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells. Biores Open Access. 2015 Jan 01;4(1):75-88. doi: 10.1089/biores.2014.0029. eCollection 2015. PMID: 26309784; PMCID: PMC4497669.
Copy Download .nbib Format: NLM
A Case Report of Rash at Peritoneal Dialysis Exit Site.

Journal of investigative medicine high impact case reports

Gosmanova EO, Ezumba I, Fisher KR, Cleveland KO.
PMID: 26668811
J Investig Med High Impact Case Rep. 2015 Nov 27;3(4):2324709615618222. doi: 10.1177/2324709615618222. eCollection 2015.

The International Society for Peritoneal Dialysis recommends the regular application of topical antibiotic-containing preparations in addition to a routine exit site care to reduce the risk of exit site infection (ESI). Among these prophylactic antimicrobial preparations, topical gentamicin is...

Cite
Gosmanova EO, Ezumba I, Fisher KR, et al. A Case Report of Rash at Peritoneal Dialysis Exit Site. J Investig Med High Impact Case Rep. 2015;3(4):2324709615618222doi: 10.1177/2324709615618222.
Gosmanova, E. O., Ezumba, I., Fisher, K. R., & Cleveland, K. O. (2015). A Case Report of Rash at Peritoneal Dialysis Exit Site. Journal of investigative medicine high impact case reports, 3(4), 2324709615618222. https://doi.org/10.1177/2324709615618222
Gosmanova, Elvira O, et al. "A Case Report of Rash at Peritoneal Dialysis Exit Site." Journal of investigative medicine high impact case reports vol. 3,4 (2015): 2324709615618222. doi: https://doi.org/10.1177/2324709615618222
Gosmanova EO, Ezumba I, Fisher KR, Cleveland KO. A Case Report of Rash at Peritoneal Dialysis Exit Site. J Investig Med High Impact Case Rep. 2015 Nov 27;3(4):2324709615618222. doi: 10.1177/2324709615618222. eCollection 2015. PMID: 26668811; PMCID: PMC4674992.
Copy Download .nbib Format: NLM
Primary Adrenal Insufficiency Misdiagnosed as Hypothyroidism in a Patient with Polyglandular Syndrome.

North American journal of medical sciences

Upala S, Yong WC, Sanguankeo A.
PMID: 27298818
N Am J Med Sci. 2016 May;8(5):226-8. doi: 10.4103/1947-2714.183014.

CONTEXT: Autoimmune polyglandular syndrome is a rare condition that causes a variety of clinical symptoms due to autoimmune processes involving multiple endocrine organs. Its vague presentation can cause missed or delayed treatment for adrenal insufficiency, resulting in a life-threatening...

Cite
Upala S, Yong WC, Sanguankeo A. Primary Adrenal Insufficiency Misdiagnosed as Hypothyroidism in a Patient with Polyglandular Syndrome. N Am J Med Sci. 2016;8(5):226-8doi: 10.4103/1947-2714.183014.
Upala, S., Yong, W. C., & Sanguankeo, A. (2016). Primary Adrenal Insufficiency Misdiagnosed as Hypothyroidism in a Patient with Polyglandular Syndrome. North American journal of medical sciences, 8(5), 226-8. https://doi.org/10.4103/1947-2714.183014
Upala, Sikarin, et al. "Primary Adrenal Insufficiency Misdiagnosed as Hypothyroidism in a Patient with Polyglandular Syndrome." North American journal of medical sciences vol. 8,5 (2016): 226-8. doi: https://doi.org/10.4103/1947-2714.183014
Upala S, Yong WC, Sanguankeo A. Primary Adrenal Insufficiency Misdiagnosed as Hypothyroidism in a Patient with Polyglandular Syndrome. N Am J Med Sci. 2016 May;8(5):226-8. doi: 10.4103/1947-2714.183014. PMID: 27298818; PMCID: PMC4899963.
Copy Download .nbib Format: NLM
An unusual presentation of a birth trauma in a newborn: A case report.

Sudanese journal of paediatrics

Hasan SAO.
PMID: 29545669
Sudan J Paediatr. 2017;17(2):68-70. doi: 10.24911/SJP.2017.2.10.

A term, male infant weighing 4.725 kg, was born vaginally to a grand multipara, diabetic mother. The birth was difficult and needed assistance with ventose. At 48 hours of birth, the infant noted to be febrile (temperature of 38.5C)...

Cite
Hasan SAO. An unusual presentation of a birth trauma in a newborn: A case report. Sudan J Paediatr. 2017;17(2):68-70doi: 10.24911/SJP.2017.2.10.
Hasan, S. A. O. (2017). An unusual presentation of a birth trauma in a newborn: A case report. Sudanese journal of paediatrics, 17(2), 68-70. https://doi.org/10.24911/SJP.2017.2.10
Hasan, Suhair A O. "An unusual presentation of a birth trauma in a newborn: A case report." Sudanese journal of paediatrics vol. 17,2 (2017): 68-70. doi: https://doi.org/10.24911/SJP.2017.2.10
Hasan SAO. An unusual presentation of a birth trauma in a newborn: A case report. Sudan J Paediatr. 2017;17(2):68-70. doi: 10.24911/SJP.2017.2.10. PMID: 29545669; PMCID: PMC5845462.
Copy Download .nbib Format: NLM
Metabolomic signatures associated with disease severity in multiple sclerosis.

Neurology(R) neuroimmunology & neuroinflammation

Villoslada P, Alonso C, Agirrezabal I, Kotelnikova E, Zubizarreta I, Pulido-Valdeolivas I, Saiz A, Comabella M, Montalban X, Villar L, Alvarez-Cermeño JC, Fernández O, Alvarez-Lafuente R, Arroyo R, Castro A.
PMID: 28180139
Neurol Neuroimmunol Neuroinflamm. 2017 Jan 27;4(2):e321. doi: 10.1212/NXI.0000000000000321. eCollection 2017 Mar.

OBJECTIVE: To identify differences in the metabolomic profile in the serum of patients with multiple sclerosis (MS) compared to controls and to identify biomarkers of disease severity.METHODS: We studied 2 cohorts of patients with MS: a retrospective longitudinal cohort...

Cite
Villoslada P, Alonso C, Agirrezabal I, et al. Metabolomic signatures associated with disease severity in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2017;4(2):e321doi: 10.1212/NXI.0000000000000321.
Villoslada, P., Alonso, C., Agirrezabal, I., Kotelnikova, E., Zubizarreta, I., Pulido-Valdeolivas, I., Saiz, A., Comabella, M., Montalban, X., Villar, L., Alvarez-Cermeño, J. C., Fernández, O., Alvarez-Lafuente, R., Arroyo, R., & Castro, A. (2017). Metabolomic signatures associated with disease severity in multiple sclerosis. Neurology(R) neuroimmunology & neuroinflammation, 4(2), e321. https://doi.org/10.1212/NXI.0000000000000321
Villoslada, Pablo, et al. "Metabolomic signatures associated with disease severity in multiple sclerosis." Neurology(R) neuroimmunology & neuroinflammation vol. 4,2 (2017): e321. doi: https://doi.org/10.1212/NXI.0000000000000321
Villoslada P, Alonso C, Agirrezabal I, Kotelnikova E, Zubizarreta I, Pulido-Valdeolivas I, Saiz A, Comabella M, Montalban X, Villar L, Alvarez-Cermeño JC, Fernández O, Alvarez-Lafuente R, Arroyo R, Castro A. Metabolomic signatures associated with disease severity in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2017 Jan 27;4(2):e321. doi: 10.1212/NXI.0000000000000321. eCollection 2017 Mar. PMID: 28180139; PMCID: PMC5278923.
Copy Download .nbib Format: NLM
Novel HPLC Analysis of Hydrocortisone in Conventional and Controlled-Release Pharmaceutical Preparations.

Journal of pharmaceutics

Adi-Dako O, Oppong Bekoe S, Ofori-Kwakye K, Appiah E, Peprah P.
PMID: 28660092
J Pharm (Cairo). 2017;2017:9495732. doi: 10.1155/2017/9495732. Epub 2017 Jun 04.

An isocratic sensitive and precise reverse phase high-performance liquid chromatography (RP-HPLC) method was developed and validated for the determination and quantification of hydrocortisone in controlled-release and conventional (tablets and injections) pharmaceutical preparations. Chromatographic separation was achieved on an ODS...

Cite
Adi-Dako O, Oppong Bekoe S, Ofori-Kwakye K, et al. Novel HPLC Analysis of Hydrocortisone in Conventional and Controlled-Release Pharmaceutical Preparations. J Pharm (Cairo). 2017;2017:9495732doi: 10.1155/2017/9495732.
Adi-Dako, O., Oppong Bekoe, S., Ofori-Kwakye, K., Appiah, E., & Peprah, P. (2017). Novel HPLC Analysis of Hydrocortisone in Conventional and Controlled-Release Pharmaceutical Preparations. Journal of pharmaceutics, 20179495732. https://doi.org/10.1155/2017/9495732
Adi-Dako, Ofosua, et al. "Novel HPLC Analysis of Hydrocortisone in Conventional and Controlled-Release Pharmaceutical Preparations." Journal of pharmaceutics vol. 2017 (2017): 9495732. doi: https://doi.org/10.1155/2017/9495732
Adi-Dako O, Oppong Bekoe S, Ofori-Kwakye K, Appiah E, Peprah P. Novel HPLC Analysis of Hydrocortisone in Conventional and Controlled-Release Pharmaceutical Preparations. J Pharm (Cairo). 2017;2017:9495732. doi: 10.1155/2017/9495732. Epub 2017 Jun 04. PMID: 28660092; PMCID: PMC5474276.
Copy Download .nbib Format: NLM
Primary adrenal insufficiency in adult population: a Portuguese Multicentre Study by the Adrenal Tumours Study Group.

Endocrine connections

Ferreira L, Silva J, Garrido S, Bello C, Oliveira D, Simões H, Paiva I, Guimarães J, Ferreira M, Pereira T, Bettencourt-Silva R, Martins AF, Silva T, Fernandes V, Pereira ML.
PMID: 29089364
Endocr Connect. 2017 Nov;6(8):935-942. doi: 10.1530/EC-17-0295. Epub 2017 Oct 31.

INTRODUCTION: Primary adrenal insufficiency (PAI) is a rare but severe and potentially life-threatening condition. No previous studies have characterized Portuguese patients with PAI.AIMS: To characterize the clinical presentation, diagnostic workup, treatment and follow-up of Portuguese patients with confirmed PAI.METHODS:...

Cite
Ferreira L, Silva J, Garrido S, et al. Primary adrenal insufficiency in adult population: a Portuguese Multicentre Study by the Adrenal Tumours Study Group. Endocr Connect. 2017;6(8):935-942doi: 10.1530/EC-17-0295.
Ferreira, L., Silva, J., Garrido, S., Bello, C., Oliveira, D., Simões, H., Paiva, I., Guimarães, J., Ferreira, M., Pereira, T., Bettencourt-Silva, R., Martins, A. F., Silva, T., Fernandes, V., Pereira, M. L. (2017). Primary adrenal insufficiency in adult population: a Portuguese Multicentre Study by the Adrenal Tumours Study Group. Endocrine connections, 6(8), 935-942. https://doi.org/10.1530/EC-17-0295
Ferreira, Lia, et al. "Primary adrenal insufficiency in adult population: a Portuguese Multicentre Study by the Adrenal Tumours Study Group." Endocrine connections vol. 6,8 (2017): 935-942. doi: https://doi.org/10.1530/EC-17-0295
Ferreira L, Silva J, Garrido S, Bello C, Oliveira D, Simões H, Paiva I, Guimarães J, Ferreira M, Pereira T, Bettencourt-Silva R, Martins AF, Silva T, Fernandes V, Pereira ML. Primary adrenal insufficiency in adult population: a Portuguese Multicentre Study by the Adrenal Tumours Study Group. Endocr Connect. 2017 Nov;6(8):935-942. doi: 10.1530/EC-17-0295. Epub 2017 Oct 31. PMID: 29089364; PMCID: PMC5712836.
Copy Download .nbib Format: NLM
Novel two wavelength spectrophotometric methods for simultaneous determination of binary mixtures with severely overlapping spectra.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Lotfy HM, Saleh SS, Hassan NY, Salem H.
PMID: 25467671
Spectrochim Acta A Mol Biomol Spectrosc. 2015 Feb 05;136:1786-96. doi: 10.1016/j.saa.2014.10.084. Epub 2014 Oct 31.

This work presents the application of different spectrophotometric techniques based on two wavelengths for the determination of severely overlapped spectral components in a binary mixture without prior separation. Four novel spectrophotometric methods were developed namely: induced dual wavelength method...

Cite
Lotfy HM, Saleh SS, Hassan NY, et al. Novel two wavelength spectrophotometric methods for simultaneous determination of binary mixtures with severely overlapping spectra. Spectrochim Acta A Mol Biomol Spectrosc. 2014;136:1786-96doi: 10.1016/j.saa.2014.10.084.
Lotfy, H. M., Saleh, S. S., Hassan, N. Y., & Salem, H. (2015). Novel two wavelength spectrophotometric methods for simultaneous determination of binary mixtures with severely overlapping spectra. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 1361786-96. https://doi.org/10.1016/j.saa.2014.10.084
Lotfy, Hayam M, et al. "Novel two wavelength spectrophotometric methods for simultaneous determination of binary mixtures with severely overlapping spectra." Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy vol. 136 (2015): 1786-96. doi: https://doi.org/10.1016/j.saa.2014.10.084
Lotfy HM, Saleh SS, Hassan NY, Salem H. Novel two wavelength spectrophotometric methods for simultaneous determination of binary mixtures with severely overlapping spectra. Spectrochim Acta A Mol Biomol Spectrosc. 2015 Feb 05;136:1786-96. doi: 10.1016/j.saa.2014.10.084. Epub 2014 Oct 31. PMID: 25467671.
Copy Download .nbib Format: NLM
Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction.

Therapeutic advances in neurological disorders

Hadden RD, Marreno F.
PMID: 25584070
Ther Adv Neurol Disord. 2015 Jan;8(1):14-9. doi: 10.1177/1756285614563056.

OBJECTIVES: To assess clinical outcomes and patient satisfaction in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) or multifocal motor neuropathy (MMN) who were switched from intravenous immunoglobulin (IVIG) to subcutaneous immunoglobulin (SCIG).METHODS: Eight consecutive patients, four with MMN and...

Cite
Hadden RD, Marreno F. Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction. Ther Adv Neurol Disord. 2015;8(1):14-9doi: 10.1177/1756285614563056.
Hadden, R. D., & Marreno, F. (2015). Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction. Therapeutic advances in neurological disorders, 8(1), 14-9. https://doi.org/10.1177/1756285614563056
Hadden, Robert D M, and Marreno, Fabrizio. "Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction." Therapeutic advances in neurological disorders vol. 8,1 (2015): 14-9. doi: https://doi.org/10.1177/1756285614563056
Hadden RD, Marreno F. Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction. Ther Adv Neurol Disord. 2015 Jan;8(1):14-9. doi: 10.1177/1756285614563056. PMID: 25584070; PMCID: PMC4286942.
Copy Download .nbib Format: NLM
Factors influencing astrocyte growth and development in defined media.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

Michler-Stuke A, Wolff JR, Bottenstein JE.
PMID: 24874398
Int J Dev Neurosci. 1984;2(6):575-84. doi: 10.1016/0736-5748(84)90035-2.

A previously described serum-free, defined medium (G2 medium) containing transferrin, selenium, hydrocortisone, biotin, fibroblast growth factor (FGF) and fibronectin developed for the growth of human and rat derived glioma cells was investigated for its ability to support proliferation of...

Cite
Michler-Stuke A, Wolff JR, Bottenstein JE. Factors influencing astrocyte growth and development in defined media. Int J Dev Neurosci. 1984;2(6):575-84doi: 10.1016/0736-5748(84)90035-2.
Michler-Stuke, A., Wolff, J. R., & Bottenstein, J. E. (1984). Factors influencing astrocyte growth and development in defined media. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2(6), 575-84. https://doi.org/10.1016/0736-5748(84)90035-2
Michler-Stuke, A, et al. "Factors influencing astrocyte growth and development in defined media." International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience vol. 2,6 (1984): 575-84. doi: https://doi.org/10.1016/0736-5748(84)90035-2
Michler-Stuke A, Wolff JR, Bottenstein JE. Factors influencing astrocyte growth and development in defined media. Int J Dev Neurosci. 1984;2(6):575-84. doi: 10.1016/0736-5748(84)90035-2. PMID: 24874398.
Copy Download .nbib Format: NLM
Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect.

Frontiers in public health

Mihailidou I, Pelekanou A, Pistiki A, Spyridaki A, Tzepi IM, Damoraki G, Giamarellos-Bourboulis EJ.
PMID: 24350219
Front Public Health. 2013 Nov 14;1:50. doi: 10.3389/fpubh.2013.00050. eCollection 2013.

OBJECTIVES: To investigate the effect of dexamethasone on triggering receptor expressed on myeloid cells-1 (TREM-1).METHODS: Wild-type and tumor necrosis factor (TNF (-/-)) mice were pre-treated with saline, dexamethasone, or hydrocortisone and exposed to a lethal infection of Pseudomonas aeruginosa....

Cite
Mihailidou I, Pelekanou A, Pistiki A, et al. Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect. Front Public Health. 2013;1:50doi: 10.3389/fpubh.2013.00050.
Mihailidou, I., Pelekanou, A., Pistiki, A., Spyridaki, A., Tzepi, I. M., Damoraki, G., & Giamarellos-Bourboulis, E. J. (2013). Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect. Frontiers in public health, 150. https://doi.org/10.3389/fpubh.2013.00050
Mihailidou, Ira, et al. "Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect." Frontiers in public health vol. 1 (2013): 50. doi: https://doi.org/10.3389/fpubh.2013.00050
Mihailidou I, Pelekanou A, Pistiki A, Spyridaki A, Tzepi IM, Damoraki G, Giamarellos-Bourboulis EJ. Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect. Front Public Health. 2013 Nov 14;1:50. doi: 10.3389/fpubh.2013.00050. eCollection 2013. PMID: 24350219; PMCID: PMC3859977.
Copy Download .nbib Format: NLM
Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia.

Annals of intensive care

Oude Lansink-Hartgring A, Hessels L, Weigel J, de Smet AMGA, Gommers D, Panday PVN, Hoorn EJ, Nijsten MW.
PMID: 26983857
Ann Intensive Care. 2016 Dec;6(1):22. doi: 10.1186/s13613-016-0124-x. Epub 2016 Mar 17.

BACKGROUND: Dysnatremia is associated with adverse outcome in critically ill patients. Changes in patients or treatment strategies may have affected the incidence of dysnatremia over time. We investigated long-term changes in the incidence of dysnatremia and analyzed its association...

Cite
Oude Lansink-Hartgring A, Hessels L, Weigel J, et al. Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia. Ann Intensive Care. 2016;6(1):22doi: 10.1186/s13613-016-0124-x.
Oude Lansink-Hartgring, A., Hessels, L., Weigel, J., de Smet, A. M. G. A., Gommers, D., Panday, P. V. N., Hoorn, E. J., & Nijsten, M. W. (2016). Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia. Annals of intensive care, 6(1), 22. https://doi.org/10.1186/s13613-016-0124-x
Oude Lansink-Hartgring, Annemieke, et al. "Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia." Annals of intensive care vol. 6,1 (2016): 22. doi: https://doi.org/10.1186/s13613-016-0124-x
Oude Lansink-Hartgring A, Hessels L, Weigel J, de Smet AMGA, Gommers D, Panday PVN, Hoorn EJ, Nijsten MW. Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia. Ann Intensive Care. 2016 Dec;6(1):22. doi: 10.1186/s13613-016-0124-x. Epub 2016 Mar 17. PMID: 26983857; PMCID: PMC4794471.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1129 entries